Published on
Mar 8, 2025
Dexcom faces FDA warning over two U.S. manufacturing sites
Dexcom said it had already submitted responses to the so-called "Form 483" and is in the process of preparing a written response.Medical device maker Dexcom said it has received a warning letter from the U.S. Food and Drug Administration …
Source:
ETManufacturing.in
-
Label Pending
